327 related articles for article (PubMed ID: 29349484)
1. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.
Ito Y; Kudo T; Kobayashi K; Miya A; Ichihara K; Miyauchi A
World J Surg; 2012 Jun; 36(6):1274-8. PubMed ID: 22270990
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and prognostic factors of patients with papillary carcinoma showing distant metastasis at surgery (M1 patients) in Japan.
Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2010; 57(6):523-31. PubMed ID: 20379035
[TBL] [Abstract][Full Text] [Related]
4. Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study.
Ito Y; Miyauchi A; Kihara M; Takamura Y; Kobayashi K; Miya A
Endocr J; 2012; 59(5):399-405. PubMed ID: 22374240
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size.
Ito Y; Fukushima M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(6):457-64. PubMed ID: 22447137
[TBL] [Abstract][Full Text] [Related]
6. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors.
Ito Y; Kudo T; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(2):119-25. PubMed ID: 22068114
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck.
Ito Y; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2011 Apr; 35(4):767-72. PubMed ID: 21181469
[TBL] [Abstract][Full Text] [Related]
9. Papillary Thyroid Carcinoma in Children and Adolescents: Long-Term Follow-Up and Clinical Characteristics.
Sugino K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Akaishi J; Masaki C; Matsuzu K; Ito K
World J Surg; 2015 Sep; 39(9):2259-65. PubMed ID: 25802237
[TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid carcinoma: prognostic index for survival including the histological variety.
Sebastian SO; Gonzalez JM; Paricio PP; Perez JS; Flores DP; Madrona AP; Romero PR; Tebar FJ
Arch Surg; 2000 Mar; 135(3):272-7. PubMed ID: 10722027
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
12. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
[TBL] [Abstract][Full Text] [Related]
13. Soft tissue invasion of papillary thyroid carcinoma.
Lin JD; Hsueh C; Chao TC
Clin Exp Metastasis; 2016 Aug; 33(6):601-8. PubMed ID: 27154220
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years.
Ito Y; Kihara M; Takamura Y; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
Endocr J; 2012; 59(7):539-45. PubMed ID: 22472193
[TBL] [Abstract][Full Text] [Related]
15. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
17. Association of patient age with high-risk pathologic features in papillary thyroid cancer.
Niemann AC; Reid AT; Smith J; Hammond J; DeBolle SA; Wei I; Soong-Ho Lee C; Hughes DT
J Surg Res; 2017 May; 211():228-232. PubMed ID: 28501122
[TBL] [Abstract][Full Text] [Related]
18. Subset analysis of the Japanese risk classification guidelines for papillary thyroid carcinoma.
Ito Y; Miyauchi A; Yamamoto M; Masuoka H; Higashiyama T; Kihara M; Miya A
Endocr J; 2020 Mar; 67(3):275-282. PubMed ID: 31776303
[TBL] [Abstract][Full Text] [Related]
19. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of carcinoma extension from primary lesions and metastatic nodes in papillary thyroid carcinoma: appropriateness of three subdivisions of extension.
Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2011; 58(11):961-7. PubMed ID: 21869536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
